15141 Fixed Dose Correction / naïve and Pre Dialysis (Europe and Asia Pacific)

PHASE2CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

February 10, 2014

Primary Completion Date

September 15, 2015

Study Completion Date

September 23, 2015

Conditions
AnemiaRenal Insufficiency, Chronic
Interventions
DRUG

BAY85-3934

25mg Tablet

DRUG

Placebo

Matching placebo tablet

Trial Locations (56)

1036

Budapest

2250

Gosford

3052

Melbourne

3400

Montana

4400

Pazardzhik

5000

Veliko Tarnovo

5300

Gabrovo

5500

Lovech

6000

Stara Zagora

6500

Baja

7623

Pécs

15706

Santiago de Compostela

26100

Cremona

27100

Pavia

40210

Düsseldorf

41100

Modena

53127

Bonn

57023

Livorno

78052

Villingen-Schwenningen

80138

Napoli

87042

Limoges Cedex1

410469

Oradea

540103

Târgu Mureş

900591

Constanța

2210001

Nahariya

3810101

Hadera

7827804

Ashkelon

06097

Halle

802-8555

Kitakyushu

831-0016

Ōkawa

050-0083

Muroran

924-8588

Hakusan

020-0066

Morioka

247-8533

Kamakura

511-0061

Kuwana

260-8712

Chiba

810-8563

Fukuoka

630-8581

Nara

15-540

Bialystok

82-200

Malbork

61-858

Poznan

26-610

Radom

70-111

Szczecin

96-300

Żyrardów

020475

Bucharest

420-767

Bucheon-si

03080

Seoul

156-707

Seoul

156-755

Seoul

08907

L'Hospitalet de Llobregat

06100

Ankara Univ. Medical Faculty, Ankara

06490

Baskent University Medical Faculty, Ankara

03540

Sifa University Medical Faculty, Izmir

CB2 0QQ

Cambridge

DN2 5LT

Doncaster

SE5 9RS

London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY